Demographics (3)
- AGE - Subject age at enrollment (phv00496067.v1.p1)
- SEX - Subject sex (phv00496066.v1.p1)
- SEX - Biological sex (phv00496061.v1.p1)
Imaging (2)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00496073.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00496080.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00496065.v1.p1)
Other (19)
- ANALYTE_TYPE - Analyte Type (phv00496071.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00496078.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00496070.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00496077.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00496060.v1.p1)
- DIAGNOSIS - Patient diagnosis (phv00496068.v1.p1)
- GEO_ACCESSION - GEO accession ID (GSM#) (phv00496083.v1.p1)
- IS_TUMOR - Tumor status (phv00496072.v1.p1)
- IS_TUMOR - Tumor status (phv00496079.v1.p1)
- POPULATION - Monocyte population defined by expression of CD14 and CD16 (phv00496074.v1.p1)
- SAMPLE_ID - Sample ID (phv00496069.v1.p1)
- SAMPLE_ID - Sample ID (phv00496076.v1.p1)
- SAMPLE_ID - Sample ID (phv00496063.v1.p1)
- SAMPLE_ID - Sample ID (phv00496082.v1.p1)
- SLAMF7_STATUS - Expression level of SLAMF7 on sorted monocyte population (phv00496075.v1.p1)
- STIMULATION - Treatment of cells in vitro (phv00496081.v1.p1)
- SUBJECT_ID - Subject ID (phv00496064.v1.p1)
- SUBJECT_ID - Subject ID (phv00496059.v1.p1)
- SUBJECT_ID - Subject ID (phv00496062.v1.p1)